Dr. Andrew Campbell
Andrew Campbell, PhD, HCLD (ABB)
Associate Director, Clinical Genomics Development
100 North Academy Avenue
Danville, PA 17822
800-695-6491
Dr. Campbell is an associate of Geisinger Medical Laboratories at Danville, Pennsylvania, where he serves as the associate director of Clinical Genomics Development.
Education:
Dr. Campbell received his PhD in pathology from and completed a postdoctoral fellowship in biomedical genetics and environmental medicine at the University of Rochester, New York.
Board Certifications
Dr. Campbell is board certified by the American Board of Bioanalysis as a high-complexity clinical laboratory director in the discipline of molecular diagnostics.
Professional Affiliations:
Association for Molecular Pathology
Research Interests:
Molecular biology and genetics, oncology, immunology, neurobiology. Dr. Campbell specializes in DNA sequencing and analysis.
Recent Academic Activity
Publications in Peer-Reviewed Journals:
Ding Y, Smith GH, Deeb K, Schneider T, Campbell A, Zhang L. Revealing Molecular Architecture of FLT3 Internal Tandem Duplication: Development and Clinical Validation of a Web-based Application to Generate Accurate Nomenclature. Int J Lab Hematol. 2022;44(5):918-927.
Ding Y, Campbell A, Zhang X, Fu K, Yuan J. Metachronous and clonally related classic Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma. Pathology. 2021;53(2):285-288.
Wang W, Ding Y, Campbell A, Handy BC, Medeiros LJ, Lin P. Biclonal presentation of lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia. Pathology. 2019;51(3):340-343.
Campbell A, Hogestyn JM, Folts CJ, Lopez B, Proschel C, Mock D, Mayer-Proschel M. Expression of the Human Herpesvirus 6A Latency-Associated Transcript U94A Disrupts Human Oligodendrocyte Progenitor Migration. Sci Rep. 2017;7(1):3978.
Abstracts, Posters, and Other Presentations:
Shah S, Campbell A, Ding Y. It is hard to treat what you can’t see: Hereditary Hemochromatosis workflow improvement at Geisinger. Presentation. 112th Annual USCAP Annual Meeting, New Orleans, Louisana, March 11-16, 2023.
Li H, Campbell A, Rovenolt R, Ding Y. Characterization of Homologous Recombination Deficiency-associated Pancreatic Ductal Adenocarcinoma using Oncomine Comprehensive Assay Plus NGS-Based Cancer Panel. Presentation. 112th Annual USCAP Annual Meeting, New Orleans, Louisana, March 11-16, 2023.
Kavus H, Campbell A, Scicchitano L, Knock B, Scicchitano M, Kershner J, Ding Y. C282Y, H63D, and S65C HFE gene mutation testing at Geisinger: A five Year Retrospective Study and Workflow Improvement. Presentation. 2022 Annual AMP Conference and Expo, Phoenix, Arizona, November 1-5, 2022.
Campbell A, Knock B, Scicchitano M, Chen G, Li H, Ding Y. Performance Evaluation of an Automated Genomic Diagnostic Assay for Myeloproliferative Neoplasms. Presentation. 2022 Annual AMP Conference and Expo, Phoenix, Arizona, November 1-5, 2022.
Swid A, Campbell A, Chen G, Ding Y. An autonomous estimation of neoplastic cellularity by molecular methodology shows promising results over the light microscopic assessment. Oral PlatformPresentation. Pennsylvania Association of Pathologists (PAP) 2022 Annual Scientific Meeting, Harrisburg, Pennsylvania, April 8-9, 2022.
Joseph N, Campbell A, Ding Y. No Bones About It: Disease Monitoring Using Next Generation Sequencing in Peripheral Blood for Patients with Myeloid Neoplasms. Presentation. 111th Annual USCAP Annual Meeting , Los Angeles, California, March 19-24, 2022.
Campbell A, Erdman R, Knock B, Scicchitano M, Ding Y. Clinical Validation of the Myeloproliferative Neoplasm Diagnostic Assay on an automated Next Generation Sequencing System. Presentation. 2021 Annual AMP Conference & Expo, Philadelphia, Pennsylvania, November 16-20, 2021.
Campbell A, Scicchitano L, Knock B, Rovenolt R, Ding Y. Performance Evaluation of an Economical, Timesaving, Quantitative Molecular Assay for Detection of BCR-ABL1 Transcripts. Presentation. 2021 Annual AMP Conference & Expo, Philadelphia, Pennsylvania, November 16-20, 2021.
Lynn TJ, Campbell A, Ding Y. Utility of Next Generation Sequencing in the Workup and Diagnosis of Myeloproliferative neoplasm in the Peripheral Blood: A single institution experience. Presentation. ASCP 2021 Annual Conference, Boston, Massachusetts, October 27-29, 2021.
Tabish N, Campbell A, Ding Y. Workflow comparison between two NCCN guideline recommended Myeloproliferative Neoplasms screening workup: A single institution’s experience. Presentation. 2020 AMP Annual Conference (Virtual and interactive), Vancouver, Canada, Novmeber 16-20, 2020.
Campbell A, Scicchitano L, Knock B, Scicchitano M, Kershner J, Ding Y. Detection of Allelic Dropout in a Mass Array HFE Genotyping Assay. Presentation. 2020 AMP Annual Conference (Virtual and interactive), Vancouver, Canada, Novmeber 16-20, 2020.
Katerji H, Katerji R, Campbell A, Rothberg P, Ding Y. Clinical Utilization of Next Generation Sequencing based Clonality Assays for Immunoglobulin Heavy Chain in Evaluating Suspected B-cell Proliferation.. Abstract. ASCP 2019 Annual Meeting, Phoenix, Arizona, September 11-13, 2019.
Campbell A, Crowe W, Spence J, Spence J, Rothberg P, Ding Y. Identification of FLT3 ITD using Next-Generation Sequencing (NGS): A single institution’s experience. Poster. Association for Molecular Pathology (AMP) 2018, San Antonio, Texas, November 1-3, 2018.
Campbell A, Crowe W, Rothberg P, Ding Y.. Clinical Evaluation of the Archer VariantPlex Myeloid Panel for Mutation Profiling in Myeloid Neoplasms. Poster. Association for Molecular Pathology (AMP) 2018, San Antonio, Texas, November 1-3, 2018.
Reyes-Barron C, Buscaglia B, Campbell A, Hicks D, Ding Y. Next Generation Sequencing for Quantitative Measurement of Human Epidermal Growth Factor Receptor-2 (HER2) Amplification: a Comparative Study. Poster. Association for Molecular Pathology (AMP) 2018, San Antonio, Texas, November 1-3, 2018.
Reyes-Barron C, Campbell A, Rothberg P, Burack R, Ding Y. Next Generation Sequencing-Assays Detect B-Lymphocyte Clonality in Formalin-Fixed Paraffin Embedded Specimens of Classical Hodgkin Lymphoma without Microdissection. Poster Presentation. USCAP 107th Annual Meeting, Vancouver, British Columbia, March 17-23, 2018.